Gracell Biotechnologies (GRCL) Enterprise Value
Price: $10.25
Market Cap: $989.87M
Avg Volume: 1.46M
Market Cap: $989.87M
Avg Volume: 1.46M
Country: CN
Industry: Biotechnology
Sector: Healthcare
Industry: Biotechnology
Sector: Healthcare
Enterprise Value Summary (Quarterly)
According to Gracell Biotechnologies's latest quarterly financial reports:
- The enterprise value (EV) is 202.98M, which includes the market capitalization, debt, and subtracts cash and cash equivalents. EV provides a more comprehensive measure of a company's total value.
- The market capitalization is 1.71B, which is calculated by multiplying the current share price by the total number of outstanding shares.
- The stock price is $21.02544, with 83.92M shares outstanding.
- The company has 1.68B in cash and cash equivalents and 115.82M in total debt.
Enterprise Value (EV) Formula:
EV = Market Cap + Total Debt - Cash and Cash Equivalents
Enterprise value is often used instead of market cap because it provides a more accurate valuation of a company by including debt and subtracting cash, giving a fuller picture of the company's total value.
Enterprise Value
$202.98M
Market Cap
$1.76B
Total Debt
$115.82M
Cash and Equivalents
$1.68B
Historical Enterprise Value
Gracell Biotechnologies Historical Enterprise Values
The table below shows various enterprise value metrics for each quarter, with the latest data available for 2023-09-30.
| Date | Enterprise Value | EV Change (%) | Stock Price | Number of Shares | Market Cap | Cash & Equivalents | Total Debt |
|---|---|---|---|---|---|---|---|
| September 30, 2023 | $202.98M | -90.77% | $21.02544 | 83.92M | $1.76B | $1.68B | $115.82M |
| June 30, 2023 | $2.20B | -1071.72% | $27.626691 | 68.13M | $1.88B | $-157.98M | $157.98M |
| March 31, 2023 | $-226.22M | 14.35% | $12.772806000000001 | 67.71M | $864.85M | $1.27B | $182.62M |
| December 31, 2022 | $-197.84M | -161.32% | $15.863559999999998 | 67.69M | $1.07B | $1.45B | $182.98M |
| September 30, 2022 | $322.63M | -71.71% | $22.90547 | 67.68M | $1.55B | $1.43B | $203.78M |
| June 30, 2022 | $1.14B | -352.89% | $36.845600000000005 | 67.67M | $2.49B | $1.54B | $182.07M |
| March 31, 2022 | $-450.93M | -153.07% | $14.77686 | 67.63M | $999.30M | $1.62B | $170.89M |
| December 31, 2021 | $849.68M | -79.84% | $38.366684 | 65.77M | $2.52B | $1.83B | $155.18M |
| September 30, 2021 | $4.21B | 12.48% | $89.41434199999999 | 67.30M | $6.02B | $1.95B | $150.42M |
| June 30, 2021 | $3.75B | -9.20% | $83.9358 | 67.23M | $5.64B | $2.05B | $153.19M |
| March 31, 2021 | $4.13B | -55.66% | $100.91004 | 60.90M | $6.15B | $2.16B | $138.63M |
| December 31, 2020 | $9.31B | -15.90% | $163.5165 | 60.90M | $9.96B | $754.31M | $102.89M |
| September 30, 2020 | $11.07B | 215.51% | $170.174942 | 65.56M | $11.16B | $156.78M | $64.88M |
| June 30, 2020 | $3.51B | -0.25% | $177.0489 | 19.81M | $3.51B | $- | $- |
| March 31, 2020 | $3.52B | 7.11% | $177.48494399999998 | 19.81M | $3.52B | $- | $- |
| December 31, 2019 | $3.28B | - | $174.460202 | 19.81M | $3.46B | $312.06M | $138.69M |
Related Metrics
Explore detailed financial metrics and analysis for GRCL.